Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$3.48
-2.5%		$6.62
$3.41
▼
$18.79
$98.23MN/A163,279 shs45,054 shs
electroCore, Inc. stock logo
ECOR
electroCore
$10.53
-2.7%		$9.24
$4.41
▼
$12.70
$95.44M187,943 shs20,468 shs
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
$0.42
+0.7%		$0.44
$0.27
▼
$0.52
$104.10MN/A174,835 shs22,550 shs
MariMed Inc. stock logo
MRMD
MariMed
$0.07
-2.9%		$0.07
$0.06
▼
$0.18
$27.40M1.35543,464 shs163,309 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-3.77%-15.20%-50.28%-67.13%+356,999,900.00%
electroCore, Inc. stock logo
ECOR
electroCore
+0.37%-4.38%+15.07%+24.52%+120.61%
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
-5.25%-1.91%-7.40%-9.47%+0.46%
MariMed Inc. stock logo
MRMD
MariMed
-6.67%-5.41%-13.69%+3.40%-53.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$3.48
-2.5%		$6.62
$3.41
▼
$18.79
$98.23MN/A163,279 shs45,054 shs
electroCore, Inc. stock logo
ECOR
electroCore
$10.53
-2.7%		$9.24
$4.41
▼
$12.70
$95.44M187,943 shs20,468 shs
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
$0.42
+0.7%		$0.44
$0.27
▼
$0.52
$104.10MN/A174,835 shs22,550 shs
MariMed Inc. stock logo
MRMD
MariMed
$0.07
-2.9%		$0.07
$0.06
▼
$0.18
$27.40M1.35543,464 shs163,309 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-3.77%-15.20%-50.28%-67.13%+356,999,900.00%
electroCore, Inc. stock logo
ECOR
electroCore
+0.37%-4.38%+15.07%+24.52%+120.61%
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
-5.25%-1.91%-7.40%-9.47%+0.46%
MariMed Inc. stock logo
MRMD
MariMed
-6.67%-5.41%-13.69%+3.40%-53.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
2.00
Hold$20.00474.71% Upside
electroCore, Inc. stock logo
ECOR
electroCore
2.00
Hold$18.0070.97% Upside
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
0.00
N/AN/AN/A
MariMed Inc. stock logo
MRMD
MariMed
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest MRMD, CNXU, ECOR, and GRUSF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
electroCore, Inc. stock logo
ECOR
electroCore
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/17/2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell (E-)
(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/A$0.21 per shareN/A
electroCore, Inc. stock logo
ECOR
electroCore
$32.03M2.96N/AN/A($0.21) per share-50.13
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
$32.43M3.21N/AN/A$0.10 per share4.20
MariMed Inc. stock logo
MRMD
MariMed
$159.83M0.17$0.02 per share3.24$0.13 per share0.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-$3.92M-$0.40N/AN/AN/AN/A-200.20%-177.26%N/A
electroCore, Inc. stock logo
ECOR
electroCore
-$13.97M-$1.66N/AN/AN/A-39.96%-1,956.38%-81.35%11/4/2026 (Estimated)
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
$3.23M-$0.02N/AN/AN/A-8.79%-14.50%-5.88%11/18/2026 (Estimated)
MariMed Inc. stock logo
MRMD
MariMed
-$14.48M-$0.04N/AN/AN/A-9.13%-10.71%-2.58%11/4/2026 (Estimated)

Latest MRMD, CNXU, ECOR, and GRUSF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/14/2026Q3 2026
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
-$0.10-$0.29-$0.19-$0.29N/AN/A
8/12/2026Q2 2026
MariMed Inc. stock logo
MRMD
MariMed
-$0.01-$0.01N/A-$0.01$39.80 million$41.93 million
8/6/2026Q2 2026
electroCore, Inc. stock logo
ECOR
electroCore
-$0.4218-$0.33+$0.0918-$0.33$9.49 million$9.45 million
8/4/2026Q2 2026
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
N/A-$0.01N/A-$0.01N/A$11.27 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
N/AN/AN/AN/AN/A
MariMed Inc. stock logo
MRMD
MariMed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
5.31
5.31
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.21
1.00
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
0.45
2.59
1.82
MariMed Inc. stock logo
MRMD
MariMed
1.78
0.92
0.34

Institutional Ownership

CompanyInstitutional Ownership
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
9.28%
MariMed Inc. stock logo
MRMD
MariMed
0.18%

Insider Ownership

CompanyInsider Ownership
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
electroCore, Inc. stock logo
ECOR
electroCore
7.80%
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
17.30%
MariMed Inc. stock logo
MRMD
MariMed
16.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
428.21 millionN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
839.02 million8.31 millionNot Optionable
Eagleford Energy Inc. stock logo
GRUSF
Eagleford Energy
118,393247.85 million204.97 millionNot Optionable
MariMed Inc. stock logo
MRMD
MariMed
260402.95 million338.28 millionNot Optionable

Recent News About These Companies

MariMed Inc. (OTCMKTS:MRMD) Sees Significant Growth in Short Interest
September 28 at 7:40 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31057802
MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation
September 24, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/marimed-s-betty-s-eddies-spreads-importance-of-cancer-screening-education-and-awareness-this-october-through-partnership-with-keep-a-breast-foundation-1036570562
MariMed's Betty's Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation
September 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/24/3368176/0/en/marimed-s-betty-s-eddies-spreads-importance-of-cancer-screening-education-and-awareness-this-october-through-partnership-with-keep-a-breast-foundation.html
MariMed cerca l’approvazione degli azionisti per un raggruppamento azionario inverso
September 23, 2026  |  it.investing.comhttps://it.investing.com/news/company-news/marimed-cerca-lapprovazione-degli-azionisti-per-un-raggruppamento-azionario-inverso-93CH-3559259
MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split
September 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/23/3367326/0/en/marimed-files-definitive-proxy-statement-for-special-meeting-of-stockholders-to-approve-proposed-reverse-stock-split.html
MariMed Announces Thrive Wellness Dispensary Opening in Columbus, Ohio
September 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/17/3363842/0/en/marimed-announces-thrive-wellness-dispensary-opening-in-columbus-ohio.html
MariMed delivers record revenue quarter as branded strategy gains momentum
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/video/marimed-delivers-record-revenue-quarter-142553742.html
Marimed anticipates incremental federal reform clarity by year-end while targeting New York brand entry in H1 2027
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4632594-marimed-anticipates-incremental-federal-reform-clarity-by-year-end-while-targeting-new-york
MariMed Inc. (MRMD) Q2 2026 Earnings Call Transcript
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936149-marimed-inc-mrmd-q2-2026-earnings-call-transcript
MariMed Inc.: MariMed Reports Second Quarter 2026 Earnings
August 13, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69299554-marimed-inc-marimed-reports-second-quarter-2026-earnings-399.htm
MariMed Reports Second Quarter 2026 Earnings
August 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/12/3344126/0/en/marimed-reports-second-quarter-2026-earnings.html
MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340157/0/en/marimed-embraces-pumpkin-season-by-unveiling-new-products-that-bring-seasonal-autumn-flavors-to-cannabis-consumers.html
MariMed Announces Second Quarter 2026 Earnings Date
July 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/15/3327576/0/en/marimed-announces-second-quarter-2026-earnings-date.html
MariMed’s Betty’s Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins
July 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/marimed-betty-eddies-expands-core-110000008.html
MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3326697/0/en/marimed-s-betty-s-eddies-expands-core-lineup-with-new-multi-vitamin-inspired-betty-s-bite-a-mins.html
MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign
July 7, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/marimed-s-nature-s-heritage-launches-the-nose-knows-immersive-science-backed-consumer-education-campaign-1036302724
MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323046/0/en/marimed-s-nature-s-heritage-launches-the-nose-knows-immersive-science-backed-consumer-education-campaign.html
MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317888/0/en/MariMed-Submits-DEA-Registration-Applications-For-State-Licensed-Medical-Cannabis-Businesses.html
MariMed Presents Fourth Annual Bob Fireman Entrepreneur of the Year Award to Weldon Angelos
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312422/0/en/marimed-presents-fourth-annual-bob-fireman-entrepreneur-of-the-year-award-to-weldon-angelos.html
Here's Why MariMed Inc. (MRMD) Could be Great Choice for a Bottom Fisher
June 15, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2937319/here-s-why-marimed-inc-mrmd-could-be-great-choice-for-a-bottom-fisher?cid=cs-stocknewsapi-ft-tale_of_the_tape|hammer_chart_pattern_(ta)-2937319

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Autonomous military drone with AV-style logo on the nose sitting on a runway, representing AeroVironment and the defense drone industry.
AeroVironment's Record Backlog and Earnings Beat Fuel Recovery Case
By Thomas Hughes | September 10, 2026
Copper pipes and sheet stacks in a warehouse open to electrical transmission towers and a power substation at sunset.
Copper Surges as Shifting Trade Policy and AI Demand Collide
By Chris Markoch | September 2, 2026
Modern aircraft hangar with a stealth fighter jet beside a large aircraft fuselage section, aerospace defense setting.
3 Under-the-Radar Defense Stocks With Record Backlogs
By Dan Schmidt | September 7, 2026
Three military surveillance drones fly near a mobile radar unit at an airfield during sunset.
3 Defense Stocks Riding the High-Energy Laser Boom
By Nathan Reiff | September 15, 2026
Oracle logo illuminated on a wall inside a data center corridor lined with server racks.
Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings
By Thomas Hughes | September 11, 2026
Conexeu Sciences stock logo

Conexeu Sciences NASDAQ:CNXU

$3.48 -0.09 (-2.52%)
As of 01:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

electroCore stock logo

electroCore NASDAQ:ECOR

$10.53 -0.29 (-2.70%)
As of 01:16 PM Eastern
This is a fair market value price provided by Massive. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Eagleford Energy stock logo

Eagleford Energy OTCMKTS:GRUSF

$0.42 +0.00 (+0.74%)
As of 12:53 PM Eastern

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.

MariMed stock logo

MariMed OTCMKTS:MRMD

$0.07 0.00 (-2.86%)
As of 12:41 PM Eastern

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas